Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk Factors for the Development of Neurological Deficits in Metastatic Spinal Disease: An International, Multicenter Delphi Study.
Huele EH, Gal R, Eppinga WSC, Verkooijen HM, O'Toole JE, Laufer I, Sciubba DM, Netzer C, Foppen W, Sahgal A, Fehlings MG, Lo SL, Fisher CG, Rhines LD, Reynolds JJ, Lazary A, Gasbarrini A, Dea N, Weber MH, Verlaan JJ. Huele EH, et al. Among authors: o toole je. Global Spine J. 2025 Jan;15(1_suppl):93S-103S. doi: 10.1177/21925682231222424. Global Spine J. 2025. PMID: 39801123 Free PMC article.
A Critical Appraisal of the Application of Frailty and Sarcopenia in the Spinal Oncology Population.
MacLean MA, Charles AJ, Georgiopoulos M, Phinney J, Charest-Morin R, Goodwin R, Laufer I, Fehlings MG, Shin J, Dea N, Rhines LD, Sahgal A, Gokaslan Z, Stephens B, Disch AC, Kumar N, O'Toole J, Sciubba DM, Netzer C, Goldschlager T, Gibbs W, Weber MH; AO Spine Knowledge Forum Tumor. MacLean MA, et al. Among authors: o toole j. Global Spine J. 2025 Jan;15(1_suppl):47S-80S. doi: 10.1177/21925682231207325. Global Spine J. 2025. PMID: 39801122 Free article.
What is the Optimal Management of Metastatic Spine Patients With Intermediate Spinal Instability Neoplastic Scores: To Operate or Not to Operate?
Kwan WC, Zuckerman SL, Fisher CG, Laufer I, Chou D, O'Toole JE, Schultheiss M, Weber MH, Sciubba DM, Pahuta M, Shin JH, Fehlings MG, Versteeg A, Goodwin ML, Boriani S, Bettegowda C, Lazary A, Gasbarrini A, Reynolds JJ, Verlaan JJ, Sahgal A, Gokaslan ZL, Rhines LD, Dea N. Kwan WC, et al. Among authors: o toole je. Global Spine J. 2025 Jan;15(1_suppl):132S-142S. doi: 10.1177/21925682231220551. Global Spine J. 2025. PMID: 39801116 Free article.
Integration of spatial multiplexed protein imaging and transcriptomics in the human kidney tracks the regenerative potential timeline of proximal tubules.
Asghari M, Sabo AR, Barwinska D, Ferreira RM, Ferkowicz M, Bowen WS, Cheng YH, Gisch DL, Gulbronson C, Phillips CL, Kelly KJ, Sutton TA, Williams JC, Vazquez M, O'Toole J, Palevsky P, Rosas SE, Waikar SS, Kiryluk K, Parikh C, Hodgins J, Sarder P, De Boer IH, Himmelfarb J, Kretzler M; Kidney Precision Medicine Project; Jain S, Eadon MT, Winfree S, El-Achkar TM, Dagher PC. Asghari M, et al. Among authors: o toole j. bioRxiv [Preprint]. 2024 Dec 2:2024.11.26.625544. doi: 10.1101/2024.11.26.625544. bioRxiv. 2024. PMID: 39677736 Free PMC article. Preprint.
Comparative analysis of the impacts of 30-day perioperative complications on patient-reported outcome measures following multilevel anterior versus posterior cervical fusion.
Bakare AA, Varela JR, Mazza J, Saganty R, Reine G, Stathopoulos J, Deutsch H, O'Toole JE, Fontes RBV, Fessler RG, Traynelis VC. Bakare AA, et al. Among authors: o toole je. J Neurosurg Spine. 2024 Dec 6:1-13. doi: 10.3171/2024.8.SPINE24257. Online ahead of print. J Neurosurg Spine. 2024. PMID: 39642365
Canadian Spine Society: 24th Annual Scientific Conference, Wednesday, February 28 - Saturday, March 2, Fairmont Chateau Whistler, Whistler, B.C., Canada.
Dionne A, Al-Zakri M, Labelle H, Joncas J, Parent S, Mac-Thiong JM, Miyanji F, Lonner B, Eren A, Cahill P, Parent S, Newton P, Dermott JA, Jaakkimainen L, To T, Bouchard M, Howard A, Lebel DE, Hardy S, Malhotra AK, Dermott J, Thevarajah D, Mathias KDA, Yoon S, Sakhrekar R, Lebel DE, Kim DJ, Hadi A, Doria A, Mitani A, Dermott J, Howard A, Lebel D, Yoon S, Mathias K, Dermott J, Lebel D, Miyanji F, Newton P, Lonner B, Bastrom T, Samdani A, Roy-Beaudry M, Beauséjour M, Imbeault R, Dufresne J, Parent S, Romeo J, Livock H, Smit K, Jarvis J, Tice A, Chan VK, Cho R, Poon S, Skaggs DL, Shumilak GK, Rocos B, Sardi JP, Charalampidis A, Gum J, Lewis SJ, Tretiakov PS, Onafowokan O, Mir J, Das A, Williamson T, Dave P, Imbo B, Lebovic J, Jankowski P, Passias PG, Lewis S, Aljamaan Y, Lenke LG, Smith J, Varshney VP, Sahjpaul R, Paquette S, Osborn J, Pelletier-Roy R, Asmussen M, Birk M, Ludwig T, Nicholls F, Zohar A, Loomans J, Pellise F, Smith JS, Kato S, Sardar Z, Lenke L, Lewis SJ, Abbas A, Toor J, Sahi G, Kovacevic D, Lex J, Miyanji F, Rampersaud R, Perruccio AV, Mahomed N, Canizares M; CSORN Investigators; Rizkallah M, Lebreton MA, Boubez G, Shen J, AlShakfa F, Kamel Y, Osman G, Wang Z, Koegl … See abstract for full author list ➔ Dionne A, et al. Among authors: o toole je. Can J Surg. 2024 Nov 13;67(6suppl1):S17-S76. doi: 10.1503/cjs.011424. Print 2024 Nov-Dec. Can J Surg. 2024. PMID: 39537311 Free PMC article. No abstract available.
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.
Davar D, Morrison RM, Dzutsev AK, Karunamurthy A, Chauvin JM, Amatore F, Deutsch JS, Das Neves RX, Rodrigues RR, McCulloch JA, Wang H, Hartman DJ, Badger JH, Fernandes MR, Bai Y, Sun J, Cole AM, Aggarwal P, Fang JR, Deitrick C, Bao R, Duvvuri U, Sridharan SS, Kim SW, A Choudry H, Holtzman MP, Pingpank JF, O'Toole JP, DeBlasio R, Jin Y, Ding Q, Gao W, Groetsch C, Pagliano O, Rose A, Urban C, Singh J, Divarkar P, Mauro D, Bobilev D, Wooldridge J, Krieg AM, Fury MG, Whiteaker JR, Zhao L, Paulovich AG, Najjar YG, Luke JJ, Kirkwood JM, Taube JM, Park HJ, Trinchieri G, Zarour HM. Davar D, et al. Among authors: o toole jp. Cancer Cell. 2024 Nov 11;42(11):1898-1918.e12. doi: 10.1016/j.ccell.2024.10.007. Epub 2024 Oct 31. Cancer Cell. 2024. PMID: 39486411 Free article. Clinical Trial.
552 results